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Abstract
The emergence in 2009 of a swine-origin H1N1 influenza virus as the first pandemic of the 21st Century is a timely reminder
of the international public health impact of influenza viruses, even those associated with mild disease. The widespread
distribution of highly pathogenic H5N1 influenza virus in the avian population has spawned concern that it may give rise to
a human influenza pandemic. The mortality rate associated with occasional human infection by H5N1 virus approximates
60%, suggesting that an H5N1 pandemic would be devastating to global health and economy. To date, the H5N1 virus has
not acquired the propensity to transmit efficiently between humans. The reasons behind this are unclear, especially given
the high mutation rate associated with influenza virus replication. Here we used a panel of recombinant H5 hemagglutinin
(HA) variants to demonstrate the potential for H5 HA to bind human airway epithelium, the predominant target tissue for
influenza virus infection and spread. While parental H5 HA exhibited limited binding to human tracheal epithelium,
introduction of selected mutations converted the binding profile to that of a current human influenza strain HA. Strikingly,
these amino-acid changes required multiple simultaneous mutations in the genomes of naturally occurring H5 isolates.
Moreover, H5 HAs bearing intermediate sequences failed to bind airway tissues and likely represent mutations that are an
evolutionary ‘‘dead end.’’ We conclude that, although genetic changes that adapt H5 to human airways can be
demonstrated, they may not readily arise during natural virus replication. This genetic barrier limits the likelihood that
current H5 viruses will originate a human pandemic.
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Introduction
Influenza pandemics occur periodically and their significant
effect on society is aptly demonstrated by the current ongoing
pandemic caused by a swine origin H1N1 subtype influenza virus
that has thus far claimed nearly 2000 lives in the span of 6 months
in mid 2009 [1]. Avian influenza H5N1 viruses have infected more
than 400 people since 2003 but no sustained human-to-human
transmission has occurred to date [2]. The reasons why H5N1 fails
to transmit among humans remain unclear especially since high
viral titres have been isolated from the nose and throat of H5N1
infected individuals [3]. The host barrier for avian influenza virus
spread in humans is multigenic. Many H5N1 isolates already
contain mutations in viral genes such as the PB2 component of the
polymerase complex that confer enhanced replication capacity in
human cells, but still this has not rendered them transmissible.
Other viral genes such as the viral hemagglutintin protein (HA) are
undoubtedly key to understanding the H5N1 virus’ pandemic
potential.
The viral hemagglutinin protein (HA) in part dictates host range
and cellular tropism of influenza virus through its preference for
different conformers of sialic acid (SA) on host cell glycans that
mediate virus attachment and facilitate infection (reviewed by [4]).
In previous studies, the distribution of SA in the human airway
epithelium has been investigated using linkage-specific lectins as
SA probes. These studies showed a2-6 SA expression was
abundant in the upper respiratory tract whereas a2-3 SA was
scarce [5]. In contrast, in the distal lung regions both a2-3 and 2–6
SA expression was significant [6,7]. While the precise nature of the
molecule(s) used by influenza virus as a receptor are not known,
sialic acid residues in the a2-6 conformer are preferentially used by
the HA proteins of human influenza viruses while avian isolate
HAs prefer SA with a2-3 linkages [8]. Significant evidence exists
that a switch in SA preference of the HA, from a2-3 to a2-6 linked
SA, is a necessary adaptation step for viruses with avian HAs to
gain the ability for human-to-human transmission. Previous
influenza pandemics of 1918, 1957 and 1968 support this
requirement as each of the respective HA genes, originating from
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avian-like viruses, mutated to increase binding preference for a2-6
SA [8,9,10]. Notably two amino acid mutations in the HA
receptor binding site (RBS) were important during the evolution of
each pandemic virus. Viral sequences from early isolates in the
pandemics suggest adaptation occurred in a stepwise manner as
isolates with just one of the two mutations have occasionally been
found [10]. Further, transmissibility of the 1918 influenza virus
between ferrets was lost after conversion of two amino acids in the
receptor binding site of HA to those of avian H1N1 viruses,
whereas mutation of a single amino acid produced a viable virus
with intermediate transmissibility [9]. Recovered sequences from
other sources of 1918 influenza viruses indicate that the
intermediate mutations also circulated during that time [10].
Whether or not the current H5N1 viruses are capable of
progressive mutations that switch their SA linkage preference is
central to an accurate risk assessment of the potential of H5N1 to
be the progenitor of a human influenza virus pandemic.
A wide range of mutations that switch receptor preference of
HA proteins have been identified and include changes throughout
the HA gene. Key amino acids at positions 226 and 228 (H3 HA
numbering) affect SA preference of several subtypes including H2,
H3, H4 and H9 [8,11,12]. On the other hand the H1 HAs that are
human adapted bear changes at positions 190 and 225 relative to
their avian precursors [9]. Mutations of the H3 HA at position
190, 193 and 194 were all previously shown to alter SA preference
[13,14]. Changes in HA that affect the extent of its glycosylation
can also profoundly affect the SA binding affinity and in vivo this
may contribute to changes in tropism and pathogenicity [15,16]. A
selection of characterized mutations were previously engineered
into recombinant H5 HA proteins and their effects on SA binding
studied with red blood cells from different species [17,18] or using
synthetic glycans which act as receptor mimetics [19,20,21]. None
of these mutations when present in H5 HA conferred a switch
from a2-3 SA binding to a2-6 SA binding using these assays.
However, SA presentation on red blood cells or as glycan mimetics
may not accurately represent SA expressed on the human airway
epithelium luminal surface. In addition, the use of lectins as probes
for SA that are utilized by influenza viruses has recently been
questioned [22,23]. Although lectins are highly specific for
terminal linkages in glycopolymer chains they do not interact
with adjacent carbohydrates. Conversely, influenza HA proteins
have more complex interactions with sialylated glycans and
binding of HA to SA are affected by glycan topology at the cell
surface [24,25]. Thus, lectins may detect SA that cannot be
utilized as receptors for influenza viruses and HA proteins may
bind more avidly to some sialylated receptors not readily detected
by lectins. Tests to assess binding of H5 and mutants thereof in
relation to host range receptor switching should therefore strive to
use models that reflect the microenvironment of the luminal
surface of the human airway epithelium.
The human airway epithelium is a well-differentiated tissue
consisting of ciliated cells and mucin-secreting cells that overlay a
basal cell layer. In vitro models of human ciliated airway epithelium
(HAE) that recapitulates the morphology, biochemistry and
physiology of the epithelium are available. Such models have
been used to study virus-host cell interactions for a number of
respiratory virus including human and avian influenza viruses
[15,26,27,28]. In particular, we and others have shown that
human and avian influenza viruses target different cell types in this
model, a tropism related to the specific SA linkage displayed on
these cells [15,29,30]. Recent data also suggest that the differential
tropism in HAE cultures may account for the compromised spread
of avian influenza viruses in the cooler conditions of the human
upper respiratory tract[31]. In this model, avian influenza viruses
exclusively infect ciliated cells whereas human influenza viruses
that showed a switch in receptor preference to predominately a2-6
SA displayed an expanded cell tropism where both ciliated cells
and non-ciliated columnar cells were infected. In addition,
preferential binding of the H1 HA of the 1918 human influenza
virus to non-ciliated cells of human tracheal tissue sections was
recently reported [25].
Here, we use HAE cultures and tissue sections of human
tracheal epithelium to determine the binding characteristics of
wild-type and select mutations of H5 HA to human airway
epithelium. In contrast to results published with short synthetic
sialylated ligands, we show that mutations in H5 HA at residue
228 effectively switch the binding pattern from an avian-like HA to
that shown by the HA of a human influenza H3 virus. Detailed
sequence analysis of codon usage at this site by H5 revealed that
although this mutation is possible, currently circulating H5N1
viruses are not poised to acquire this amino acid change easily.
Our findings confirm the potential for H5 to adapt to human
airway epithelial cell receptors but suggest that it is unlikely to
occur within the quasi-species present in an infected individual.
Our data offers a rationale for why H5N1 viruses have not yet
evolved into human transmissible strains with pandemic potential.
Results
Expression and glycan binding of synthetic H5 HA
proteins
We generated recombinant wild-type and mutant H5 HAs and
used them as probes to determine their ability to bind to SA on the
luminal surface of human airway epithelium. For our wild-type H5
HA we chose the A/Vietnam/1194/04 H5N1 isolate (accession
number: AY651333), as this virus was isolated from an infected
human lung but was not associated with human-to-human
transmission. Wild-type H5 HA was cloned as a fusion protein
with the Fc domain of human immunoglobulin heavy chain as a
immunological tag and expressed as a soluble molecule in the
supernatant of recombinant baculovirus-infected insect cells
(Figure 1A and [32]). We then introduced either single or double
mutations at Q226L and G228S in the SA binding site of H5 HA
[21] equivalent to those previously shown to switch receptor
specificity in H2 and H3 HA subtypes [8]. Our previous work has
shown these mutations alter red blood cell binding by H5 HA
[18]. Equivalent mutations have not been documented in H5N1
viruses isolated in nature. For comparison, we also generated a
S227N mutant identified in several human H5N1 virus isolates
and reported to show changes in SA binding profiles in synthetic
glycan assays [33]. All HA mutants were similarly expressed using
recombinant baculoviruses and were secreted from infected Sf9
cells at similar level to the wild-type H5 HA protein [32]
(Figure 1B). A solid phase binding assay was used to evaluate the
binding of the HA-Fc proteins to short synthetic receptor mimics
bearing a single copy of lactosamine with terminal SA in the a2-3
(3SLN) and a2-6 linkage (6SLN) (Figure 2) [32]. As expected, H5
HA bound to 3SLN and not to 6SLN whereas H3 HA cloned
from the recently circulating human H3N2 virus (A/Panama/
2007/99, accession number: CY034100) showed the opposite
preference. Most of the H5 HA mutants retained affinity for the
3SLN glycopolymer. Interestingly, mutant Q226L did not bind to
either of the sialyated lactosamine ligands tested in this assay. We
therefore assayed Q226L H5 HA mutant protein for binding to
the conventional a2-3SA lactose ligand, 3SL, since this has been
reported by others [33]. In agreement with the previous report, we
found that both wild type H5 HA protein and the Q226L mutant
bound efficiently to the 3SL ligand confirming that the Q226L
H5 Binding to Human Trachea
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protein was correctly folded and represented a relevant ligand for
our further studies. Of all the H5 HA mutants tested, only S227N
acquired affinity for 6SLN in accordance with previous findings
[33]. This mutant also retained 3SLN affinity, although it was
reduced compared to that of the wild-type H5 HA.
Binding of HA proteins to an in vitro model of human
airway epithelium
The human airway epithelium, the predominant site of human
influenza virus infection, contains a mixture of ciliated and non-
ciliated epithelial cell types. Ciliated cells are abundant and can be
identified morphologically by the presence of cilia and immuno-
logically by antibodies directed against their expression of
acetylated a-tubulin. Amongst the non-ciliated epithelial cell
populations, pre-ciliated cells, mucin-secreting (Goblet cells), and
other secretory cells may be present depending on the anatomical
site examined (Figure 3A and Figure 4A). We and others have
shown that using in vitro models of human ciliated airway
epithelium (HAE), human influenza viruses infect both ciliated
and non-ciliated cells, while avian influenza viruses infect only
ciliated cells [15,34]. In HAE, a2-3 SA expression detected by
MAA lectin binding was evident at the tips of cilia and on the
apical surface of ciliated cells likely at the level of the microvilli.
MAA binding was only rarely seen on cells that lacked obvious
cilia. In contrast, SNA lectin binding detected a2-6 SA on the
apical surface of both ciliated and non-ciliated cells [15].
Since the recombinant HA-Fc proteins should represent more
biologically relevant ligands than lectins for airway surface SAs
utilized by influenza viruses, we used the HA-Fc fusion proteins to
probe the apical surfaces of HAE, detecting HA binding with an
anti-human IgG antibody conjugate. The dimeric HAs were pre-
complexed into larger multimers by mixing with anti-human Fc
antibodies before application to the tissue. When applied en face,
H3 HA-Fc predominately bound to non-ciliated cells (Figure 3B),
a finding that was confirmed when histological sections of HAE
were similarly probed and immuno-reactivity for H3 HA-Fc
localised predominately to the apical surface of non-ciliated cells
(Figure 3C). In contrast, avian H5 HA-Fc bound sporadically to
the apical surfaces of HAE and was only detected in association
with cells that co-stained with acetylated a-tubulin, i.e., ciliated
cells (Figure 3D and 3E). Binding of H5 HA was concentrated at
the levels of the microvilli on ciliated cells as opposed to the shafts
of cilia (Figure 3E), similar to the binding of the MAA lectin
previously described [15].
H5 HA mutants Q226L and S227N bound to ciliated cells at
the level of the microvilli similar to the parental avian H5 HA
(Figure 3F and 3G). However, the G228S mutant showed an
expanded binding profile that included binding to non-ciliated cell
types in addition to ciliated cells (Figure 3H). The HA mutant
bearing G228S in combination with the Q226L mutation also
bound to both ciliated and non-ciliated cells (Figure 3I and 3J)
indicating a partial switch in cell tropism.
The binding of each mutant to the different cell types was
quantified by counting at least five different fields of view containing
a total of 100–200 cells. Figure 3K shows that the H3 HA protein
bound to approximately 60% of the HAE cells and the majority of
those bound were of the non-ciliated type. In contrast all of the H5
HA proteins bound to fewer cells and of the cells bound the majority
were ciliated although the mutants containing the G228S change
bound to some cells that were non-ciliated (dark blue).
Binding of HA proteins to human airway epithelium
tissue sections
To determine if HA interaction with HAE cultures is predictive
for human airway epithelium in vivo we next probed histological
sections of freshly excised human tracheal airway tissue with
recombinant HA-Fc. Similar cell types were present in the tracheal
airway tissues as observed in HAE cultures confirming published
data that HAE cultures recapitulate the morphology of the
tracheal airway epithelium (Figure 4A). When HA-Fc were used to
probe the human tracheal airway sections, H3 HA-Fc bound
extensively to the luminal surface of the tissue and was localized at
the apical surfaces of cells. H3 HA bound predominantly to non-
ciliated cells in the tracheal sections, but also bound to some
ciliated cells both at the level of microvilli as well as, in some cases,
to the tips of the cilia (Figure 4B). In contrast, H5 HA-Fc bound
only sporadically to ciliated cells at the level of microvilli
(Figure 4C). The single mutants Q226L and S227N bound to
ciliated cell microvillus regions (Figure 4D and 4E), similar to wild-
type H5 HA (Figure 3E). In addition, some binding of the S227N
mutant to cilia was observed (Figure 4E). In contrast, HA with the
G228S single mutation bound to both ciliated cells and non-
ciliated cells (Figure 4G). The combined Q226L/G228S mutation
exhibited a strikingly similar binding pattern to that shown by the
H3 HA, with binding predominately localized to the apical surface
of non-ciliated cells (Figure 4G versus 4B).
Once again the extent of binding of each mutant to the different
cell types was quantified by counting cells in at least five different
fields of view (Figure 4H). This clearly demonstrated that the double
mutant Q226L/G228S bound both to more cells in the section and
showed an altered preference for the non-ciliated cell type in
comparison with the wild type H5 HA. The extent of binding by
G228S and the double mutant approached but did not reach the
55% of cells bound by the human adapted H3HA. Moreover
although the S227N HA mutant showed some binding to the cilia
tips (Figure 4E), analysis of several fields of cells obtained from
Figure 1. Expression of recombinant HA-Fc proteins. (A)
Recombinant baculoviruses encoding HA from a recent H3N2 human
virus, (A/Panama/2007/99) or from a highly pathogenic H5N1 avian
influenza virus (A/Vietnam/1194/04), were generated as previously
described [32]. The HA proteins were expressed as soluble proteins
secreted from infected Sf9 cells by removing the HA transmembrane
(TM) and cytoplasmic tail (CT) portions of the protein and replacing the
HA signal peptide (SP) with the signal peptide of the baculovirus
envelope protein gp64 (SP gp64). The HA proteins were tagged at the
C-terminus by a human Fc (HuFc) and hexa-histidine (His6) tags. (B) All
recombinant HA proteins were expressed at similar levels as
determined by western blot analysis using an anti-human Fc antibody.
doi:10.1371/journal.pone.0007836.g001
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Figure 2. Binding of recombinant HA proteins to synthetic receptor ligands 3SLN (avian receptor) and 6SLN (human receptor) in a
solid phase assay. (A) Synthetic glycans on polyacrylamide linkers were immobilized on 96-well plates following UV treatment. Recombinant HA
proteins were preformed into higher order complexes by incubation with anti-human Fc before incubation on the plate and detection with goat anti-
human IgG conjugated to horse-radish peroxidise (HRP). (B) Recombinant HA-Fc proteins were adsorbed on 96 well plates coated with anti-human Fc
antibody. Synthetic glycans on polyacrylamide linkers with biotin tags (6SLN and 3SL) were incubated on the plates and detected with Streptavidin –
HRP conjugate.
doi:10.1371/journal.pone.0007836.g002
H5 Binding to Human Trachea
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Figure 3. Recombinant HA proteins bind to human airway epithelial (HAE) cultures. (A) Morphological features of HAE cultures visualized
by H&E counterstain. Cell types present include ciliated cells (C), mucin-secreting cells (MS) and non-ciliated cells (NC). HAE cultures were probed with
recombinant HA proteins from human H3 (A/Panama/2007/99) (B,C) or avian H5 (A/Vietnam/1194/04) (D,E) viruses either directly to the apical surface
of fixed cultures (B,D) or to histological sections (C,E). Receptor binding site mutants of H5 HA (F–J) were also analysed for binding to histological
sections. Ciliated cells were identified using anti acetylated a-tubulin (green) and the HA-Fc proteins were visualized with anti human-Fc (red). Images
are representative of cell-type binding seen in experiments. (K) Numbers and types of epithelial cells bound by HA proteins were quantified by
counting 100–200 total cells from five different fields of view.
doi:10.1371/journal.pone.0007836.g003
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Figure 4. Recombinant HA proteins bind to human tracheal airway epithelium. (A) Morphological features of human tracheal airway
epithelium ex vivo visualized by H&E counterstain indicating cell-types present: (C) ciliated cell, (NC) non-ciliated cell, (MS) mucin secreting cell.
Histological sections of ex vivo human tracheal tissue were probed with recombinant HA proteins cloned from human H3 (B), or avian H5 (C) influenza
viruses or with H5 HA receptor binding mutants (D–G). Ciliated cells are identified with anti acetylated a-tubulin (green) and the HA-Fc proteins
detected with anti human-Fc (red). White arrows indicate cells that exhibit HA binding. Open arrowheads indicate ciliated cells with HA binding, solid
arrowheads indicate non-ciliated cells with HA binding and the small arrow indicates binding to tops of cilia. These are representative images and
similar patterns were seen in repeated experiments. (H) Numbers and types of epithelial cells bound by HA proteins were quantified by counting
100–200 total cells from five different fields of view.
doi:10.1371/journal.pone.0007836.g004
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different patients did not reveal any binding to the non-ciliated cell
type, in contrast to the G228S containing mutants.
To confirm that the binding of HA-Fc observed in these studies
was SA dependent, tracheal airway sections were exposed to
recombinant neuraminidase before probing with HA-Fc. Treat-
ment with neuraminidase (NA) cloned from Salmonella typhimurium
LT2, which displays a 260-fold substrate preference for a2-3 SA
over a2-6 SA [35] abrogated binding of H5 HA-Fc to human
trachea epithelium (Figure 5B, middle panel). Binding of H3 HA-
Fc to the tops of cilia was also markedly reduced after treatment
Figure 5. Recombinant HA proteins from human and avian influenza viruses bind ex vivo human tracheal epithelium in a sialic acid
dependant manner. Histological sections of ex vivo human tracheal epithelium were probed with human H3 (A), avian H5 (B) or H5 mutants, (C)
G228S, and (D) Q226L/G228S, with and without prior neuraminidase (NA) treatment. Slides were pre-incubated for 3 hours with 5 units of
recombinant NA cloned from Salmonella typhimurium LT2 (NEBL) that shows a 260-fold preference for a2-3 over a2-6 linked SA or with 15 units of
recombinant NA cloned from Clostridium perfringens (NEBL) that cleaves both a2-3 and a2-6 SA linkages. HA was detected as before using anti-
human Fc (red) and anti-acetylated a-tubulin was used to indicate ciliated cells (green). White arrows indicate cells that exhibit HA binding. Open
arrowheads indicate ciliated cells with HA binding; solid arrowheads indicate non-ciliated cells with HA binding.
doi:10.1371/journal.pone.0007836.g005
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with the a2-3 specific NA, but binding to the apical surface of cells
lacking cilia persisted (Figure 5A, middle panel). However,
treatment with a broad specificity NA isolated from Clostridium
perfringens abolished both the H3 and H5 HA binding (Figure 5A
and 5B, right hand panel). The binding of the single or double
mutants containing the G228S mutation on ciliated cells was
abolished by treatment with a2-3-specific NA (compare Figure 5C
and 5D, left panel, open triangles, with Figure 5C and 5D, middle
panel). However, binding of these HA proteins to non-ciliated cells
(solid triangles) remained unless the broad specificity NA from C.
perfringens was used (Figure 5C and 5D, right panel).
Analysis of H5 HA codon usage at amino acid 228
Our data show a specific amino acid mutation inH5HA is sufficient
to switch an avian virus-like binding profile (ciliated cells) to a human
virus-like binding profile (ciliated and non-ciliated cells) in tracheal
airway epithelium in vitro and ex vivo. The mutation enabling this event
is a change in amino acid position 228 from G to S which likely
increases the affinity of HA for the long chain a2-6 SA lactosami-
noglycans in the previously reported ‘umbrella’ topology [21,24].
While change of H5 HA specificity is experimentally possible, the
propensity for the requisite mutations to occur in vivo depends on the
feasibility of the circulating strains of H5N1 virus acquiring the
necessary nucleotide changes. We assessed whether principles of
codon usage would enable such a mutation to occur in the context
of natural virus. An amino acid switch from glycine to serine at
residue 228 requires either one or two nucleotide changes
depending on the nature of the third ‘wobble’ nucleotide in the
glycine codon. All of the 1374 influenza H5 HA gene sequences
deposited in the available databases show that H5 viruses encode
G228 using codons GGA (93%) or GGG (7%) (Figure 6A).
Therefore, generation of a G228S mutation in H5 HAmust involve
one of three possibilities: 1) Simultaneous mutation of two
nucleotides, the frequency of which is calculated to be lower than
the maximum viral load of 108 copies of vRNA would allow [3],
assuming an error rate of 1025 mutations per site [36]; 2)
Transversion at the third nucleotide of the codon to generate a
neutral intermediate that is unlikely to become enriched within the
quasispecies; or, 3) Passage through an intermediate in which either
the first nucleotide of the codon mutates initially to encode arginine
by transition, or the second nucleotide of the codon mutates by
transversion to encode alanine (Figure 6A). To assess the latter
possibilities, we generated H5 HA-Fcs representing the G228R and
G228A intermediates and tested their binding to synthetic
glycopolymers, HAE and human tracheal airway tissue
(Figure 6B–6G). Mutant G228A was unaffected in synthetic ligand
binding compared to wild-type H5 HA (Figure 6E versus Figure 2)
and bound sporadically to ciliated cells in HAE and tracheal tissue.
Thus, this amino acid change would confer no advantage to a virus
in the human respiratory tract. Mutant G228R failed to bind any of
the synthetic ligands and did not bind any cells in HAE or tracheal
tissue. Moreover, when the mutated H5 HA genes were used in
attempts to rescue live influenza virus using reverse genetics we were
unable to rescue viruses containing the G228R mutation. This is
consistent with the notion that a G228R H5 HA is not capable of
generating a viable intermediate during the evolution of a receptor
switched virus. In contrast, viruses with wild-type H5 HA RBS or
bearing other amino acid changes at residue 228 such as G228A or
G228S were rescued (data not shown).
Discussion
We address potential reasons why H5N1 avian influenza virus
has not yet adapted for human-to-human transmission in spite of
the unprecedented distribution and frequent zoonoses of this avian
influenza virus. Text book explanations of the origins of influenza
virus pandemics describe that reassortment of genes from avian
strains and human strains give rise to pandemic viruses. One
possible explanation why this event has not occurred for H5N1
could be an incompatibility between the H5 HA gene and other
genes of currently circulating human influenza viruses. However,
laboratory-generated recombinant viruses have shown that surface
antigen genes from South East Asian H5N1 viruses are compatible
with internal viral genes from currently circulating H3N2 human
strains and coinfection of ferret in a laboratory setting produced in
vivo reassortants with mixtures of genes derived from human
circulating virus and H5N1 [37,38]. Whether there is an
impediment to the reassortment happening in nature is not
resolved. In addition, an increasing body of work supports the
notion that reassortment per se is not sufficient to generate a
pandemic. Importantly, both unmodified H5N1 avian influenza
viruses and laboratory generated chimeric human: avian reassor-
tant viruses with unmodified H5N1 surface antigens failed to
transmit between ferrets, the most relevant animal model for
studies of human-like transmissibility of influenza viruses [39,40].
Moreover, similar work with other avian subtypes of influenza
virus indicate that mutations in the receptor binding site of HA
that switch the SA preference are required for efficient
transmission in the ferret model. For example, avian influenza
viruses of the H7 subtype North American lineage that have
undergone such a receptor switch showed transmission between
ferrets in a direct contact model [41]. Similarly, H9N2 viruses
whose HA genes display enhanced preference for a2-6SA binding
were transmitted between co-housed ferrets whereas viruses with
HAs that bound to a2-3SA were not [12].
By analogy with these other avian subtypes and in light of the
experiences of previous pandemics [8,9] we judge that adaptation
of H5 HA at the RBS will be required for human-to-human
transmissibility. Our data, summarized in Figure 6, provide a
rational explanation of why H5 HA has not yet adapted in this
way. By analysis of codon usage required to generate mutants
capable of SA switching, we found that two or more simultaneous
nucleotide changes are required to adapt the H5 HA gene for
efficient binding to cells of the human tracheal epithelium.
Moreover, our data indicate that single nucleotide change
intermediates would be predicted to reduce viral fitness in the
environment of the human airways. Indeed, attempts to generate
such single nucleotide mutants in the context of infectious H5N1
virus indicate they are either non-viable or display attenuated
growth kinetics (unpublished work).
Although some naturally occurring H5 HA mutants with
increased affinity for synthetic human receptor mimics, including
the S227N mutation considered here, have been detected within
the quasispecies of viruses isolated from H5N1 infected patients
[33,42,43,44], none of them have resulted in documented human-
to-human transmission of the virus suggesting that acquisition of
binding to synthetic ligands is not an adequate predictor of
transmissibility. Mutations spread throughout the HA protein have
been found to affect receptor binding affinity and preference in the
context of other HA subtypes [8,9,13,14,15,20]. Although we
cannot claim that the mutations we describe are the only ones that
will switch receptor binding preference of H5 HA, extensive
investigation of pandemic evolution [45] coupled with the
cumulative research of several groups [18,20] suggest they are
the most likely candidates. Moreover, the failure of H5N1 to
emerge as a pandemic strain despite the wide variety of species
infected since 2003 suggests that there is a significant natural
barrier to the evolution of H5 HA receptor binding specificity.
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The reasons why HA of avian influenza virus has to adapt its
RBS before acquiring human transmissibility are still not
explained in detail. Studies utilizing lectin probes suggest a paucity
of a2-3SA in the upper respiratory tract [9]. Our data shows that
H5 HA protein can bind to a2-3SA on human airway epithelium
but that the cell specificity of the binding differs from that shown
by a human influenza HA. Interestingly the binding of H5 HA for
synthetic a2-3sialylated glycans showed a different pattern than
that shown for the human para-influenza viruses that also bind to
the ciliated cell in human airway and transmit effectively between
humans [27] Although replication of H5N1 virus in human nasal
tissue ex vivo has been demonstrated [23], the scenario during
Figure 6. Nucleotide sequence changes required to switch H5 HA receptor binding preference. (A) Analysis of codon usage by 1374 H5
influenza viruses indicates that codon 228 is GGA in 93% strains and GGG in 7%. The table illustrates transversions and transitions by which coding
capacity at this residue might change from glycine to serine. The ability of the two intermediate mutants 228R (B) and 228A (E) recombinant HA
proteins to bind synthetic receptor ligands 3SLN (avian receptor) and 6SLN (human receptor) in a solid phase assay was assessed. The binding
phenotype on HAE (C,F) or human tracheal epithelium (D,G) by recombinant proteins with each amino acid sequence changed at residue 228 are
shown (C,D) G228R and (F,G) G228A.
doi:10.1371/journal.pone.0007836.g006
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actual transmission events between human hosts may be more
limiting. In these cases, virus attachment might only occur to
certain cell types that are in a specific anatomical location or that
most abundantly display the relevant ligand.
Our findings that mutations in the H5 HA gene can alter
receptor binding in the human airway epithelium may have
implications for the generation of effective live attenuated
vaccines. Although they are unlikely to be used during the pre-
pandemic period due to the risk that reassortment with circulating
strains might generate a novel virus with pandemic potential itself,
live attenuated H5N1 vaccines may represent an important dose
sparing strategy for wide scale vaccination of the population in the
face of an ongoing pandemic with highly pathogenic H5N1 virus.
Indeed, cold adapted influenza viruses with wild-type H5N1
surface antigens have been tested, but their immunogenicity in
ferrets and in humans have been disappointing to date [46]. Using
reverse genetics, the Q226L and G228S mutations could be
artificially engineered in recombinant H5 HA within the cold
adapted backbone. This may increase the vaccine virus’ ability to
replicate in the human upper respiratory tract and thus induce a
more substantive immune response leading to the effective
immunological memory required for good vaccine efficacy.
H5N1 continues to circulate and diversify [2] and some
mutations accrued since 2004 may enhance the virus’ capacity
for receptor switching [21]. It is also noteworthy that lesser studied
subtypes of avian influenza may be evolutionarily closer to
receptor switching than previously assumed [11,12,41]. Tissue
binding assays such as those described here will be useful in
assessing the pandemic potential of such viruses. The widespread
preparedness for an influenza pandemic that has resulted from the
prevalence of H5N1 therefore remains appropriate even in light of
the data we present.
Materials and Methods
Expression of influenza HA protein in insect cells
Spodoptera frugiperda cells (Sf9) were grown in suspension in
BioWhittaker Insect-Xpress serum-free media (Cambrex) supple-
mented with 2% fetal calf serum. They were infected with
recombinant baculovirus expressing H3-Fc, H5-Fc or H5-Fc
receptor binding mutants and incubated at 28uC. After 72 h the
supernatant was harvested by centrifugation at 4000 rpm for
10 min to remove the infected cells. The soluble protein was
concentrated by centrifugation at 4500 rpm for 4 h using Vivaspin
columns (Viva Science, Sartorius Group). The yield of concen-
trated protein ranged from 500–700 mg/mL. Protein was
aliquoted and stored at 280uC.
Binding of HA-Fc proteins to human airway epithelial
culture and tracheal airway tissue sections
Paraffin embedded sections of cultured human airway epithe-
lium or normal human tracheal sections were obtained from UNC
Cystic Fibrosis Center Core facility. HAE derived from at least 3
codes and tracheal sections from 3 individuals were used in this
study and representative images are shown. There was no notable
difference between cultures or sections from different individuals.
The sections were deparaffinized and rehydrated. Non-specific
binding was blocked using 3% bovine serum albumin (BSA) in
phosphate-buffered saline (PBS) for 1 hour at room temperature
(RT) before incubation with ligands. Concentrated baculovirus
supernatants containing H3, H5 or H5 HA and mutant proteins
were pre-complexed with goat anti-human IgG (Fc specific)
antibody (Invitrogen) at a ratio of 5 mg of HA-Fc: 0.6 mg of
antibody, for 1 hour at 4uC. Sections were incubated with pre-
complexed HA-Fc in 1% BSA in PBS ON at 4uC or RT for
3 hours. After washing in PBS-T, slides were incubated with rabbit
anti-acetylated a-tubulin in 1% BSA in PBS for 3 hours RT or
overnight (ON) at 4uC. Following washing with PBS-T (PBS with
0.05% Tween-20), antibody-incubated slides were immersed in
1% BSA in PBS containing donkey anti-goat FITC (Immunolo-
gicals Direct) and donkey anti-rabbit Alexafluor 647 (Invitrogen)
for 1 hour at RT. Slides were washed with PBS-T and viewed
under a confocal microscope. Images were collected on a Zeiss
Pascal LSM5 laser scanning microscope using Axioplan2 imaging
software using a Plan-Apochromat 6361.4 oil Ph3 lens. The
binding of each mutant to the different cell types was quantified by
counting at least five different fields of view containing a total of
100–200 cells.
Sialidase treatment of tissue sections
Five units of a2-3 sialic acid-specific neuraminidase from
Salmonella typhimurium or 15 units of a a2-3/a2-6 dual specificity
enzyme from Clostridium perfingens were incubated with deparaffi-
nized sections for 3 hours at 37uC. Sections were then washed in
PBS-T before being probed with recombinant HA proteins as
above.
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